# Pfizer Inc: Form 13F holdings

An institutional investment manager in New York, NY. SEC CIK 78003.

- Quarter ended: 2026-06-30
- Filed: 2026-08-13
- Reported value: $170.4m
- Positions: 17 (20 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/78003/000007800326000102/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ALLOGENE THERAPEUTICS INC (ALLO)](/companies/allo.md) | COM | $46.9m | 27.5% | 22,032,040 |  | Unchanged |
| [CELCUITY INC (CELC)](/companies/celc.md) | COM | $29.6m | 17.3% | 295,652 |  | Unchanged |
| [ARVINAS INC (ARVN)](/companies/arvn.md) | COM | $27.7m | 16.2% | 3,457,815 |  | Unchanged |
| [PYXIS ONCOLOGY INC (PYXS)](/companies/pyxs.md) | COMMON STOCK | $19.5m | 11.4% | 7,032,770 |  | Unchanged |
| WAVE LIFE SCIENCES LTD | SHS | $10.9m | 6.4% | 1,875,000 |  | Unchanged |
| BIOHAVEN LTD | COM | $8.0m | 4.7% | 505,645 |  | Unchanged |
| [CARIBOU BIOSCIENCES INC (CRBU)](/companies/crbu.md) | COM | $7.9m | 4.6% | 4,690,431 |  | Unchanged |
| [SPERO THERAPEUTICS INC (SPRO)](/companies/spro.md) | COM | $5.3m | 3.1% | 2,362,348 |  | Unchanged |
| [ZENTALIS PHARMACEUTICALS INC (ZNTL)](/companies/zntl.md) | COM | $3.9m | 2.3% | 953,834 |  | Unchanged |
| [ORIC PHARMACEUTICALS INC (ORIC)](/companies/oric.md) | COM | $3.6m | 2.1% | 372,904 |  | Reduced −4,407,497 |
| [CARDIFF ONCOLOGY INC (CRDF)](/companies/crdf.md) | COM | $3.0m | 1.8% | 2,411,575 |  | Unchanged |
| ZURA BIO LTD | CLASS A ORD SHS | $2.9m | 1.7% | 538,841 |  | Reduced −2,300,072 |
| [AGOMAB THERAPEUTICS NV (AGMB)](/companies/agmb.md) | ADS | $1.0m | 0.6% | 75,000 |  | Unchanged |
| [BOLT BIOTHERAPEUTICS INC (BOLT)](/companies/bolt.md) | COM NEW | $133.8k | <0.1% | 31,305 |  | Unchanged |
| [NEXTCURE INC (NXTC)](/companies/nxtc.md) | COM NEW | $73.0k | <0.1% | 44,347 |  | Reduced −109,007 |
| [GINKGO BIOWORKS HOLDINGS INC (DNA)](/companies/dna.md) | CL A NEW | $30.0k | <0.1% | 2,928 |  | Unchanged |
| SENSEONICS HLDGS INC | COM | $12.4k | <0.1% | 2,171 |  | Unchanged |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [Q32 BIO INC (QTTB)](/companies/qttb.md) | COM | $0 | 0.0% | 0 |  | Sold out −101,618 |

Source: SEC EDGAR, Form 13F-HR, accession 0000078003-26-000102. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.